Although CEA is used for CRC diagnostics in combination with other examination methods, due to its low sensitivity and specificity, this biomarker is usually used in monitoring the effectiveness of the treatment and CRC recurrence (1). This evidence concerns the gene CEACAM5 and colorectal carcinoma.